Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining -0.49% today. In the last week its performance is 3.93%, and 18.51% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 183.88, so today’s gain of -0.49% is a significant step towards its target price. The GAP today is therefore -0.25%.
Amgen Inc. (NASDAQ:AMGN), has a market cap of 128037.04, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 80.20%.
At the current price of 172.44, it has a dividend yield of 2.65%, and its target price is 183.88. This is with a profit margin of 33.60%, and total debt/equity of 1.16. Amgen Inc. (NASDAQ:AMGN) has a P/E of 16.89, as well as a forward P/E of 13.51.
With a current EPS of 10.26, and a forecasted EPS growth for next year at 3.95%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 20.50%. For the next five years EPS growth is projected to be 6.79%.
Performance for the year is 18.47%. Since its IPO date on 9/7/1984, the total performance to date is 19.34%.
Volume today for Amgen Inc. (NASDAQ:AMGN), is 1585989, while its average volume is 3587.29. Whilst the total gain today was -0.49%, it did have a day high of -0.53%.
Volatility for this week has been at 1.84%, and 1.73% for the month. The 52-week low for Amgen Inc., AMGN has been 30.80%, while the 52-week-high has reached -1.16%.
Looking at its return of investments, which is 13.00%, and its return on assets is 10.10%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 42.60%. With a sales growth of 7.70% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 1.01, and has a current ratio of 4.1 and 3.9 for quick ratio.
So what is the value of Amgen Inc.? Well its PEG is 2.49, and the P/S is 5.57, along with a P/B of 4.27. Meanwhile it has a p/cash of 3.36.